This article has Open Peer Review reports available.
In vivo study of experimental pneumococcal meningitis using magnetic resonance imaging
© Brandt et al; licensee BioMed Central Ltd. 2008
Received: 15 March 2007
Accepted: 14 January 2008
Published: 14 January 2008
Magnetic Resonance Imaging (MRI) methods were evaluated as a tool for the study of experimental meningitis. The identification and characterisation of pathophysiological parameters that vary during the course of the disease could be used as markers for future studies of new treatment strategies.
Rats infected intracisternally with S. pneumoniae (n = 29) or saline (n = 13) were randomized for imaging at 6, 12, 24, 30, 36, 42 or 48 hours after infection. T1W, T2W, quantitative diffusion, and post contrast T1W images were acquired at 4.7 T. Dynamic MRI (dMRI) was used to evaluate blood-brain-barrier (BBB) permeability and to obtain a measure of cerebral and muscle perfusion. Clinical- and motor scores, bacterial counts in CSF and blood, and WBC counts in CSF were measured.
MR images and dMRI revealed the development of a highly significant increase in BBB permeability (P < 0.002) and ventricle size (P < 0.0001) among infected rats. Clinical disease severity was closely related to ventricle expansion (P = 0.024).
Changes in brain water distribution, assessed by ADC, and categorization of brain 'perfusion' by cortex ΔSI(bolus) were subject to increased inter-rat variation as the disease progressed, but without overall differences compared to uninfected rats (P > 0.05). Areas of well-'perfused' muscle decreased with the progression of infection indicative of septicaemia (P = 0.05).
The evolution of bacterial meningitis was successfully followed in-vivo with MRI. Increasing BBB-breakdown and ventricle size was observed in rats with meningitis whereas changes in brain water distribution were heterogeneous. MRI will be a valuable technique for future studies aiming at evaluating or optimizing adjunctive treatments
The development of bacterial meningitis is associated with multiple pathophysiological changes in brain homeostasis. Previously, this has been investigated experimentally using different methodologies to determine the kinetics of infection and inflammation; loss of blood-brain-barrier and blood-labyrinth-barrier; damage to brain cortex, hippocampus and white matter; development of brain oedema; alterations in brain blood supply and loss of cerebral vascular autoregulation [1–6]. However, experimental investigations of the interaction between these pathophysiological measures have been limited, probably due to complexity and incompatibility of the methodologies applied. Recent bioluminescence studies illustrate the apparent limitation of a single method, where the optical technique is able to visualize the dynamics of the progressing meningeal infection but does not provide information relating to disease induced physiological changes [7, 8].
Whilst magnetic resonance imaging (MRI) has been widely used for the study of experimental stroke , its application has been limited in studies of experimental meningitis [10–12], with reported studies primarily focusing on visualization of meningeal enhancement and hydrocephalus at low resolution. When compared to experimental stroke studies that aim to produce single lesions localised in predetermined anatomical sites, bacterial meningitis results in diffuse and unpredictable involvement of brain vasculature and parenchyma that is often complicated by systemic infection .
In clinical neuroinfections, including meningitis, MRI has primarily been used as a diagnostic tool to assess brain pathology, intracranial complications and to evaluate responsiveness to treatment [14, 15], despite MRI's capability to provide quantifiable in vivo data on BBB function, brain water distribution as well as indices of cerebral blood supply .
Consequently, MRI methodology was used to acquire multi-parametric in-vivo data to characterize temporal changes during the course of experimental pneumococcal meningitis in the rat model. MR measures of inflammation, vascular permeability, brain water, brain contrast agent supply and pathoanatomy were obtained together with clinical and paraclinical data, in both infected and control animals. Identification of parameters that report on the disease progress may be used in future studies to assess and optimize therapeutic strategies.
The experimental protocol was approved by the Danish Animal Inspectorate (Dyreforsoegstilsynet). Adult male Wistar rats (280–300 g) were used for the experiments. Normal day/night cycles and free access to food and water were provided.
Experimental study design
Guidelines for clinical disease score and motorical performance score.
(Held by the tail, normally the front paws grip the edge of i.e. a table)
(Hind legs are placed below a table edge. Normal reaction is an immediate grip of the edge).
(Plate with an upward slope of 30 degrees. The rat will normally crawl upwards and grip the top edge).
Both legs grip the table edge and is cabaple of "walking along the edge".
Movements slower. Can still be activated.
Both legs grips the edge. No movement.
Seeking to grip the table edge.
Does nor crawl upwards but spreads legs to hold on.
Prefers to stay in the same place. Nose is still active. Still climbing, Paws are seeking.
Only one leg grips the edge or no gripping.
Does not grip the edge.
Developing problems with controlling the limbs. Does not move. Tilting. Front paws sliding.
Paresis of one or more extremities.
Normal eyes and surroundings.
Activity reduced, Turns easily if laid on the back.
Slow turning if laid on the back.
Haemorrhage around eyes. Scrathcing of eyes.
Pilo-erection and untended fur.
Does not turn around.
Lying on the side.
A Streptococcus pneumoniae type 3 strain (68034, Statens Serum Institut (SSI), Copenhagen, Denmark) was used for the experiments . The infectious inoculum was diluted in cold saline to a final concentration of 2–5 × 105 CFU/ml, as confirmed by quantitative cultures. On the day of inoculation, rats were anaesthetized subcutaneously with 3 ml/kg weight of an aqueous solution (10 ml sterile water) of Hypnorm© (2 ml)/Dormicum© (4 ml, 5 mg/ml)/Atropine (1.5 ml, 1 mg/ml) and injected intracisternally with 30 μl of the bacterial suspension or saline using a butterfly syringe. After MR investigation, cerebrospinal fluid (CSF) and blood was obtained by cisterna magna- and tail-vein puncture from each animal. White blood cell (WBC) counts in CSF were measured on an automatic cell counter (Swelab Autocounter AC 920, Swelab Instruments, Sweden) using 20 μl of CSF. Bacterial counts in CSF were determined by plating 10-fold serial dilutions of 20 μl CSF. Fifty μl of undiluted blood and 50 μl of a 20-fold dilution were plated. CSF from uninfected controls was plated undiluted.
Assessment of clinical disease, motor performance and disease severity (Table 1)
Clinical appearance and motor-function scores were determined prior to each scanning session. The scoring method was based on previous reports and fitted to the present model of disease [1, 16, 17], see Table 1. Overlap between scores was evident since, for example, ambulatory activity would be affected by clinical disease.
MR imaging was performed using a Varian SISCO 4.7 Tesla imaging and spectroscopy system. Rats were positioned in a stereotactic device placed within a home-built quadrature coil. The animals were kept warm using a thermostatically controlled blanket with circulating warm water (35°C). All rats underwent T1-weighted (T1W), T2-weighted (T2W), quantitative diffusion, dynamic MRI (dMRI) and post contrast T1W measurements whilst anaesthetized as described above. To enable direct comparison of the imaging data, the same 12 contiguous coronal slices were acquired for the T1W, T2W and diffusion measurements. The acquisitions using a b-value = 0 provided the T2W images.
ADC – Apparent diffusion coefficient mapping
Quantitative diffusion measurements (single in-plane direction, along the x-axis) were performed before the administration of contrast agent (echo time (TE) = 80 ms, repetition time (TR) = 2000 ms, matrix size (MA) = 128 × 128, field of view (FOV) = 40 × 40 mm, number of transients (NT) = 1 with b-values of 0, 185, 740, 1665 s/mm2). Regions of interest (ROI) were drawn by hand around cerebral neo-cortex, excluding the meninges. A circular ROI was used in the basal ganglia. ROI's were drawn independently by two of the authors (HS and CTB) blinded to all other data. ROI's were drawn and mean ADC's calculated using MATLAB©.
Dynamic MRI – Loss of blood-brain-barrier (BBB) integrity and contrast agent bolus induced changes in signal intensity (ΔSI(bolus)) in cerebral cortex and muscle (Fig. 2)
T1W images (TE = 11 ms, TR = 450 ms, SL = 1.8 mm, MA = 128 × 256, FOV = 40 mm × 40 mm, NT = 4, 12 contiguous slices) were acquired before and directly after acquisition of dMRI. Dynamic MRI data was acquired using a bolus administration of contrast agent (Magnevist, Schering AS) administered via a cannulated tail vein. The contrast agent, containing gadolinium diethylene triamine pentaacetic acid (GdDTPA), was injected within 10 seconds, at a dose of 0.5 mmol/kg. Bolus passage was followed using a dMRI protocol where 100 sets of FLASH T1W images (3 slices) were obtained with 10 images acquired before and 90 images acquired after a single injection of contrast agent (TE = 4 ms, TR = 11 ms, flip angle (FL) = 7°, SL = 1 mm, MA = 128 × 128, FOV = 40 × 40 mm, NT = 1).
Loss of BBB integrity – contrast agent bolus induced changes in signal intensity (ΔSI(bolus)) in cerebral cortex
An automated selection of cerebral cortex was performed via standard image processing methods. Thresholding and morphology were used to identify the full brain mask including ventricles, basal ganglia and the base of the brain. Morphological erosion and subsequent subtraction then extracted a region of interest, which was then halved to obtain the cortex used for analysis (see Fig. 2b). Data and results from the cortex voxels are presented as the fraction of the total number of voxels in each brain cortex selection.
A preliminary analysis of the dynamic MRI data sets using k-means clustering was performed to identify specific enhancement patterns associated with normal and infected animals. From this analysis, typical enhancement profiles were identified which could be divided into temporal regions. Consequently, data was divided into 2 major classes (non-enhancing and enhancing) and into 3 sub-classes of cortex ΔSI(bolus) values: 1) high, 2) medium and 3) low. Enhancing and non-enhancing voxels were classified according to whether significant T1-weighted enhancement occurred within the voxel following gadolinium administration. Sub-classification of the 3 cortex ΔSI(bolus) values was performed according to the extent of T2* signal loss during the bolus passage. The T2* signal loss is dependent on the concentration and distribution of gadolinium within the tissue and will, consequently, be dependent on a variety of physiological parameters including perfusion, blood volume, flow and vascular permeability and dimensions. Hence, whilst the extent of signal loss only reflects tissue perfusion, the approach does provide a semi-quantitative parameter that gives an indication of how meningitis affects brain and muscle physiology.
A class of high muscle ΔSI(bolus) was identified in intrinsic- and extrinsic muscle in the rat head including jaw and temporal muscle. This class was not observed within the brain compartment and analysis was based on extra-cranial pixels identified by visualizing the rat head subtracting all other profiles thus clearly showing only the muscle relief of the rat head. Consequently, the analysis did not use ROI's but used extra-cranial pixels automatically assigned to the class. A reduced number of voxels in this cluster was interpreted as a reduction in muscular blood supply. Data for the infected animals are presented as a fraction of the corresponding control rat value at each time point since the study design was performed so that 2 meningitis rats were matched with one control. Failure to acquire complete data from one 48 hour control rat meant that correspondent data from 2 infected rats were unavailable.
Measurement of ventricle-brain ratio (Fig. 1)
Regions of interest around whole brain and lateral- and third ventricles were drawn on T2W images. The ventricle-brain ratio (VBR) was calculated as ventricular area divided by total brain area for all three coronal slices included. Regions of interest (ROI's) and measurements were performed in MATLAB© and done blinded to all other data (HS).
After MR investigation, rats were euthanized with pentobarbital (200 mg/ml) and perfused with 1.5% paraformaldehyde (PFA) via the left ventricle of the heart. Brains were harvested and stored for 14 days in 1.5% PFA and frozen in n-hexane mixed and cooled with dry-ice. Two 45 μm thick coronal cryosections adjacent to each other, corresponding to the MR images obtained were stained with Hematoxylin & Eosin (HE) in order to identify the nature of pathological features apparent in the MR images.
Data are presented as mean +/- SEM. Comparisons between controls and infected rats were performed by two-way ANOVA and P < 0.05 was considered significant.
Due to the temporal development of the disease, two-way ANOVA was performed in 3 intervals for each dataset; 6 to 48 hours, 6 to 30 hours and 36 to 48 hours after infection.
Statistical comparisons between infected and control animals were only performed between MRI-generated datasets. Since muscle ΔSI(bolus) data were presented as a fraction of results obtained in the correspondent control, a linear regression analysis of this dataset was performed.
To identify relationships between clinical, paraclinical and MRI data, Spearman Rank correlations were performed among meningitis rats in the terminal disease phase, 36 to 48 hours after infection. Since only a limited number of comparisons were performed, a P-value below 0.05 was also considered significant for correlation analysis.
As shown in Fig. 3, the increase in the paraclinical (CSF and blood bacterial counts, CSF WBC) and MRI data (ventricle-brain ratio (VBR), Apparent Diffusion Coefficient (ADC) and dynamic MRI (dMRI)) was non-linear as the disease progressed with time. The dual phase nature of the increases suggested that this model of the disease could be characterised by a Developing disease phase (up to and including 30 hours after infection) followed by a Terminal disease phase (from 36 to 48 hours).
All CSF samples obtained from control rats were sterile. CSF and blood samples taken 6 to 48 hours after infection delineated the progression of meningitis with increasing CSF bacterial growth, secondary bacteremia and increasing CSF inflammation. Both CSF WBC and CSF bacterial counts peaked at 30 hours after infection. A plateau relieved by a downward slope in CSF WBC and CSF bacterial counts was observed in samples obtained from 30 hours onwards, declining until the final 48 hour study point. Blood bacterial counts showed that secondary bacteremia was present in one rat from 12 hours after infection and 3/4 rats at 24, 30 and 36 hours and 4/4 rats at 42 and 48 hours.
As expected, clinical disease severity increased in infected animals as the disease progressed. Subsequent to increasing clinical scores, motor performance, mainly ambulatory activity, deteriorated. Increasing inter-rat variation in both clinical and motor performance scores was observed as the infection developed, being marked from 30 hours onwards. In the terminal disease phase (36 to 48 hours) no further change in the scores was observed in either clinical or motor performance scores among infected rats. Infected rats imaged at 36, 42 and 48 hours after infection were comparable with respect to clinical disease and motor performance.
Following intracisternal inoculation of saline, clinical disease was not observed among these control rats although slight post-anaesthetic drowsiness (the Animal Inspectorate required animals to be transported to the MR centre whilst anaesthetised) accounted for a score of 1 in one control at 6 hours after inoculation.
The extent of ventricle expansion, determined as the ventricle-brain ratio (VBR), was comparable between controls and infected rats up to 30 hours post-infection at which time point 3 out of 4 infected rats had increased VBR compared to controls. When compared to controls, the VBR was significantly increased among infected rats in the total study period (6 to 48 hours, Two-way ANOVA, P < 0.0001) as well as the terminal phase of meningitis (36 to 48 hours, P < 0.0001), but not in the developing phase (6 to 30 hours, P = 0.40).
In the terminal disease phase, a significant association was found between VBR, severity of clinical disease and motor disability (Spearmann rank, rho = 0.62, P = 0.024 and rho = 0.57, P = 0.04) whereas an inverse correlation was found between increased VBR and the fraction of enhancing brain cortex indicative of increased BBB permeability (rho = -0.73, P = 0.01) as well as the muscle perfusion ratio (rho = -0.75, P = 0.019).
Loss of BBB integrity (Fig. 3f)
A measure of BBB integrity was obtained in 26 infected and 13 control rats. Increased BBB permeability, measured as the fraction of cortex voxels enhancing due to gadolinium leakage, was observed in one rat with meningitis as early as 6 hours after infection. From 36 hours onwards, all infected rats (n = 11) had increased BBB permeability when compared to corresponding controls (n = 5). The maximum fraction of enhancing voxels was found from 30 to 42 hours after infection. Compared to the control group, the total fraction of enhancing brain voxels was significantly increased during the full course of disease as well as in the terminal phase (6 to 48 hours, Two-way ANOVA, P = 0.0019 and 36 to 48 hours, P = 0.019), but did not quite reach significance during the developing phase (6 to 30 hours, P = 0.06).
ΔSI(bolus) values were obtained from 26 infected and 13 control rats. The marked shift towards enhancing cortex voxels, and thus increased BBB permeability, in rats with meningitis, was also apparent in the analysis of cortex ΔSI(bolus) values based on gadolinium bolus passage. In infected rats, the selected cortex region (Fig. 2) shifted from non-enhancing high-, medium- and low-ΔSI(bolus) values towards enhancing high-, medium-, and low-ΔSI(bolus) cortical values. This shift towards increased BBB permeability was significant in all 3 classes of ΔSI(bolus) values in comparison with the control groups (6 to 48 hours, Two-way ANOVA, high, P = 0.017, medium, P = 0.0018 and low, P = 0.012). However, the total fraction of high-, medium- and low-ΔSI(bolus) cortical values (non-enhancing + enhancing) did not change significantly among infected rats in comparison with controls in either the developmental stage (6 to 30 hours, Two-way ANOVA, high, P = 0.97, medium, P = 0.99, and low, P = 0.98), terminal stage (36 to 48 hours, high, P = 0.78, medium, P = 0.71, and low, P = 0.2) or full course of disease (6 to 48 hours, high, P = 0.8, medium, P = 0.76, and low, P = 0.9). Within the control group, one 24 hour and one 42 hour rat had markedly reduced ΔSI(bolus) values comparable to the most affected infected rats. The number of high ΔSI(bolus) values in muscle were equally low in these control rats.
Muscle ΔSI(bolus) values (Fig. 3i)
Data from 24/29 infected rats was successfully analyzed. The number of voxels representing high ΔSI(bolus) muscle values in infected rats, relative to corresponding controls at each time point, showed a steady decline as infection progressed (Linear regression analysis, borderline significant, P = 0.05).
Apparent Diffusion Coefficient (ADC) values were obtained in 28 infected rats and 13 controls. Increased variability in ADC values in cerebral cortex and basal ganglia was observed among infected rats in comparison with the highly uniform control group.
However, no significant differences in cortex ADC was found comparing infected rats to controls in either developing or terminal disease stages (6 to 48 hours, Two-way ANOVA, P = 0.47; 6 to 30 hours, P = 0.12; 36 to 48 hours, P = 0.67). Also, basal ganglia ADC was not significantly different between infected rats and controls (6 to 48 hours, P = 0.38; 6 to 30 hours, P = 0.062; 36 to 48 hours, P = 0.47).
Brain injury (Fig. 5)
Focal injury to the brain parenchyma, other than hydrocephalus, was observed in four rats in the terminal stage of meningitis (two rats after 36 hours, one rat after 42 hours and one rat after 48 hours). Injury presented as a localized infarction, haemorrhage and abscess formation, the latter being readily observable on T1W post contrast images whereas the other lesions were smaller and less obvious on MR images.
Few studies have combined MRI and experimental pneumococcal meningitis research . The present study is the first to use minimally invasive in-vivo MRI methods to describe the development of brain pathoanatomy and pathophysiology in a meningitis model. Within 24 hours after infection, MRI was able to detect physiological changes as the disease developed. In the terminal disease phase, the most marked results obtained with MRI were the significant expansion of ventricles and increased BBB permeability. Cortex brain water distribution (ADC) also changed but appeared to be subject to variation making interpretation of the data less obvious. Regions of high ΔSI(bolus) muscle values declined as infection progressed, whereas the included classes of cortex ΔSI(bolus) values were not subject to significant changes.
Hydrocephalus is a well-known complication of bacterial meningitis associated with poor outcome and brain injury [18–20], and preliminary studies directed at reducing intracranial pressure appear promising . This study describes a marked expansion of ventricles that appears to develop, in the terminal disease stage  in close association with development of severe clinical disease and deteriorating motor performance. This is in agreement with recent findings of a close association between clinical disease score and intracranial pressure .
A hallmark of bacterial meningitis is the loss of BBB integrity allowing CSF leukocyte accumulation and diffusion of water and plasma constituents into brain parenchyma. In the present study, permeability of the vascular barrier increased markedly as meningitis progressed. This was visualized by the accumulation of contrast agent surrounding brain cortex and in the ventricles (Fig. 4). The loss of BBB integrity appeared to be an efficient disease biomarker, making it possible to identify infected and control animals at early time points after infection. In comparison to methodology previously applied to investigate BBB integrity such as Evans Blue staining , MRI enabled quantification and visualization of areas with increased BBB permeability that were confined to the outer layers of cerebral cortex (see Fig. 2). The close association between increased VBR and low fraction of enhancing cortex and thus a low BBB permeability suggests that expansion of the ventricles may influence cortex perfusion and via physical compression alter, for example, interstitial volume. This may account for the observed changes in brain water distribution and contrast agent kinetics even though the present study failed to identify the association between the two parameters.
Brain water content has in previous experimental meningitis studies been shown to increase as a consequence of the infectious and inflammatory response [24–26]. To some extent, this is in accord with our measurements of ADC, reflecting altered water distribution in the extracellular compartment (vasogenic oedema ) in cerebral cortex and basal ganglia in the majority of infected rats in the developmental stage of meningitis. Normalisation, or decrease, of ADC was observed in the terminal stage of meningitis and could be related to the concomitant ventricle expansion, as has previously been shown . In the early stages of meningitis, increased brain water content may reflect increased blood volume. This would be in agreement with previous findings of increased cerebral blood flow in early meningitis and changes in ADC could thus be due to alterations in blood flow and volume [24, 29]. This study has not investigated the distribution of water between tissue and ventricles. Future studies measuring ventricular size and ADC in combination with wet/dry weight analysis would provide further mechanistic insight into this characteristic of the disease.
Our measurement of ΔSI(bolus) values due to contrast agent induced T2* effects during the bolus passage in cerebral cortex was not subject to any significant overall changes whereas the area of high ΔSI(bolus) muscle values declined as infection progressed. The latter being in agreement with studies of muscle perfusion in septicaemia showing areas of well perfused muscle to decrease as septicaemia worsens [30–32]. Previous studies have shown that cerebral perfusion is compromised in bacterial meningitis as a consequence of systemic disease, brain oedema, and raised intracranial pressure [3, 33, 34]. Our experimental data cannot support this as a general assumption, since we found a large variation within ΔSI(bolus) categories in the terminal phase of meningitis where only seven of 15 rats between 30 and 48 hours after infection presented an increased fraction of low ΔSI(bolus) brain areas (Fig. 3l). Our ΔSI(bolus) results were limited to the cortex, a region that has previously been shown experimentally to be more well perfused, even in severely ill subjects , and in patients to be subject to great variation and regional differences . It is important to state that the ΔSI(bolus) measure of 'perfusion' reported here is dependent on a number of other physiological factors and only partly on perfusion.
Several limitations in the presented study should be considered. Firstly, biological variation in disease development and the limited numbers of animals used makes temporal comparison sub-optimal. Whilst the sacrifice of rats at designated time points was performed to ensure histopathological evaluation, this limited the study of pathophysiological events preceding a poor outcome. Imaging of rats on more than one occasion would have significantly improved analysis of inter-relationships. Furthermore, the study design is limited by the relatively short time course of the disease and image acquisition times. The dynamic MRI measurements provided only a semi-quantitative measure that only partly reflects perfusion. Hence the crude categorization and dependency of the ΔSI(bolus) values on other parameters including blood volume clearly indicates that future studies could be further optimized. Quantitative perfusion measurements could be performed following sequence optimisation to acquire kinetic changes in relaxation times following gadolinium administration. The gadolinium concentration could then be fitted to appropriate kinetic models to obtain measurements of vascular permeability, extracellular volume and perfusion. Also, ADC measurements may be improved by introducing measurement of water motion in three or even more planes as compared to the single plane performed here. In addition, the necessary use of a total anaesthesia during scanning sessions affects pathophysiological parameters and result in changes in vasodilatation, blood pressure, blood supply or ventilation  in a disease-dependent way.
Even though our study was performed using a dedicated 4.7 Tesla animal scanner, the resolution was not optimal and small lesions in the cerebral cortex were not readily recognized as areas with lesions until after the histopathological evaluation of the corresponding specimen. The discrepancy between the extent of gadolinium distribution and histopathology shown in Fig. 5 is probably due to standard histological methods being unable to identify early neuronal loss since we have previously shown abscesses to be surrounded by a bright halo of ballooning or necrotic neurons . The advantages of working at higher magnetic field strengths enabling higher resolution MRI images to be acquired and would be of significant benefit when comparing MR and histological images.
The present study has shown the ability of MR methods to monitor in-vivo changes in brain pathoanatomy and pathophysiology as meningitis progresses. Measurement of BBB breakdown and dilation of ventricles has identified parameters that are related to disease severity. MRI is therefore of significant value for the development and evaluation of new and successful therapeutic approaches.
This work was supported in part from the following foundations: Lundbeck Fonden, Augustinus Fonden, Eivind Eckbos dansk-norske Legat; Lily Benthine Lunds Fond; Direktør Jacob Madsen og Hustru Olga Madsens Fond; SSAC fondet; Alfred Benzon's Fond. We would like to thank Jacob Vang for providing expert technical assistance.
- Leib SL, Clements JM, Lindberg RL, Heimgartner C, Loeffler JM, Pfister LA, Tauber MG, Leppert D: Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain. 2001, 124: 1734-1742. 10.1093/brain/124.9.1734.View ArticlePubMedGoogle Scholar
- Tauber MG, Borschberg U, Sande MA: Influence of granulocytes on brain edema, intracranial pressure, and cerebrospinal fluid concentrations of lactate and protein in experimental meningitis. J Infect Dis. 1988, 157: 456-464.View ArticlePubMedGoogle Scholar
- Koedel U, Scheld WM, Pfister HW: Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis. 2002, 2: 721-736. 10.1016/S1473-3099(02)00450-4.View ArticlePubMedGoogle Scholar
- Brandt CT, Lundgren JD, Lund SP, Frimodt-Moller N, Christensen T, Benfield T, Espersen F, Hougaard DM, Ostergaard C: Attenuation of the bacterial load in blood by pretreatment with granulocyte-colony-stimulating factor protects rats from fatal outcome and brain damage during Streptococcus pneumoniae meningitis. Infect Immun. 2004, 72: 4647-4653. 10.1128/IAI.72.8.4647-4653.2004.View ArticlePubMedPubMed CentralGoogle Scholar
- Ostergaard C, Yieng-Kow RV, Benfield T, Frimodt-Moller N, Espersen F, Lundgren JD: Inhibition of leukocyte entry into the brain by the selectin blocker fucoidin decreases interleukin-1 (IL-1) levels but increases IL-8 levels in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits. Infect Immun. 2000, 68: 3153-3157. 10.1128/IAI.68.6.3153-3157.2000.View ArticlePubMedPubMed CentralGoogle Scholar
- Pedersen M, Brandt CT, Knudsen GM, Ostergaard C, Skinhoj P, Frimodt-Moller N, Moller K: Cerebral blood flow autoregulation in early experimental S. pneumoniae meningitis. J Appl Physiol. 2007, 102: 72-78. 10.1152/japplphysiol.00697.2006.View ArticlePubMedGoogle Scholar
- Orihuela CJ, Gao G, McGee M, Yu J, Francis KP, Tuomanen E: Organ-specific models of Streptococcus pneumoniae disease. Scand J Infect Dis. 2003, 35: 647-652. 10.1080/00365540310015854.View ArticlePubMedGoogle Scholar
- Kadurugamuwa JL, Modi K, Coquoz O, Rice B, Smith S, Contag PR, Purchio T: Reduction of astrogliosis by early treatment of pneumococcal meningitis measured by simultaneous imaging, in vivo, of the pathogen and host response. Infect Immun. 2005, 73: 7836-7843. 10.1128/IAI.73.12.7836-7843.2005.View ArticlePubMedPubMed CentralGoogle Scholar
- Dijkhuizen RM, Nicolay K: Magnetic resonance imaging in experimental models of brain disorders. J Cereb Blood Flow Metab. 2003, 23: 1383-1402. 10.1097/01.WCB.0000100341.78607.EB.View ArticlePubMedGoogle Scholar
- Wiesmann M, Koedel U, Bruckmann H, Pfister HW: Experimental bacterial meningitis in rats: demonstration of hydrocephalus and meningeal enhancement by magnetic resonance imaging. Neurol Res. 2002, 24: 307-310. 10.1179/016164102101199792.View ArticlePubMedGoogle Scholar
- Narayana PA, Wolinsky JS, Jensen DJ: Magnetic resonance imaging of experimental mumps meningoencephalitis in suckling hamsters. Magn Reson Med. 1987, 4: 597-601. 10.1002/mrm.1910040611.View ArticlePubMedGoogle Scholar
- Mathews VP, Kuharik MA, Edwards MK, D'Amour PG, Azzarelli B, Dreesen RG: Dyke award. Gd-DTPA-enhanced MR imaging of experimental bacterial meningitis: evaluation and comparison with CT. AJR Am J Roentgenol. 1989, 152: 131-136.View ArticlePubMedGoogle Scholar
- Brandt CT, Lundgren JD, Frimodt-Moller N, Christensen T, Benfield T, Espersen F, Hougaard DM, Ostergaard C: Blocking of leukocyte accumulation in the cerebrospinal fluid augments bacteremia and increases lethality in experimental pneumococcal meningitis. J Neuroimmunol. 2005, 166: 126-131. 10.1016/j.jneuroim.2005.05.014.View ArticlePubMedGoogle Scholar
- Kastrup O, Wanke I, Maschke M: Neuroimaging of infections. NeuroRx. 2005, 2: 324-332. 10.1602/neurorx.2.2.324.View ArticlePubMedPubMed CentralGoogle Scholar
- Jan W, Zimmerman RA, Bilaniuk LT, Hunter JV, Simon EM, Haselgrove J: Diffusion-weighted imaging in acute bacterial meningitis in infancy. Neuroradiology. 2003, 45: 634-639. 10.1007/s00234-003-1035-8.View ArticlePubMedGoogle Scholar
- Tupper DE, Wallace RB: Utility of the neurological examination in rats. Acta Neurobiol Exp (Wars). 1980, 40 (6): 999-1003.Google Scholar
- Garcia JH, Wagner S, Liu KF, Hu XJ: Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke. 1995, 26: 627-634.View ArticlePubMedGoogle Scholar
- Mactier H, Galea P, McWilliam R: Acute obstructive hydrocephalus complicating bacterial meningitis in childhood. BMJ. 1998, 316: 1887-1889.View ArticlePubMedPubMed CentralGoogle Scholar
- Wang KW, Chang WN, Chang HW, Wang HC, Lu CH: Clinical relevance of hydrocephalus in bacterial meningitis in adults. Surg Neurol. 2005, 64: 61-65. 10.1016/j.surneu.2004.10.009.View ArticlePubMedGoogle Scholar
- Hoppe-Hirsch E, Laroussinie F, Brunet L, Sainte-Rose C, Renier D, Cinalli G, Zerah M, Pierre-Kahn A: Late outcome of the surgical treatment of hydrocephalus. Childs Nerv Syst. 1998, 14: 97-99. 10.1007/s003810050186.View ArticlePubMedGoogle Scholar
- Lindvall P, Ahlm C, Ericsson M, Gothefors L, Naredi S, Koskinen LO: Reducing intracranial pressure may increase survival among patients with bacterial meningitis. Clin Infect Dis. 2004, 38: 384-390. 10.1086/380970.View ArticlePubMedGoogle Scholar
- Malipiero U, Koedel U, Pfister HW, Leveen P, Burki K, Reith W, Fontana A: TGFbeta receptor II gene deletion in leucocytes prevents cerebral vasculitis in bacterial meningitis. Brain. 2006, 129: 2404-2415. 10.1093/brain/awl192.View ArticlePubMedGoogle Scholar
- Papadopoulos MC, Verkman AS: Aquaporin-4 gene disruption in mice reduces brain swelling and mortality in pneumococcal meningitis. J Biol Chem. 2005, 280: 13906-13912. 10.1074/jbc.M413627200.View ArticlePubMedGoogle Scholar
- Pfister HW, Koedel U, Lorenzl S, Tomasz A: Antioxidants attenuate microvascular changes in the early phase of experimental pneumococcal meningitis in rats. Stroke. 1992, 23: 1798-1804.View ArticlePubMedGoogle Scholar
- Koedel U, Pfister HW, Tomasz A: Methylprednisolone attenuates inflammation, increase of brain water content and intracranial pressure, but does not influence cerebral blood flow changes in experimental pneumococcal meningitis. Brain Res. 1994, 644: 25-31. 10.1016/0006-8993(94)90342-5.View ArticlePubMedGoogle Scholar
- Tauber MG: Brain edema, intracranial pressure and cerebral blood flow in bacterial meningitis. Pediatr Infect Dis J. 1989, 8: 915-917.View ArticlePubMedGoogle Scholar
- Loubinoux I, Volk A, Borredon J, Guirimand S, Tiffon B, Seylaz J, Meric P: Spreading of vasogenic edema and cytotoxic edema assessed by quantitative diffusion and T2 magnetic resonance imaging. Stroke. 1997, 28: 419-426.View ArticlePubMedGoogle Scholar
- Massicotte EM, Buist R, Del Bigio MR: Altered diffusion and perfusion in hydrocephalic rat brain: a magnetic resonance imaging analysis. J Neurosurg. 2000, 92: 442-447.View ArticlePubMedGoogle Scholar
- Slater AJ, Berkowitz ID, Wilson DA, Traystman RJ: Role of leukocytes in cerebral autoregulation and hyperemia in bacterial meningitis in rabbits. Am J Physiol. 1997, 273: H380-H386.PubMedGoogle Scholar
- Ellis CG, Bateman RM, Sharpe MD, Sibbald WJ, Gill R: Effect of a maldistribution of microvascular blood flow on capillary O(2) extraction in sepsis. Am J Physiol Heart Circ Physiol. 2002, 282: H156-H164.PubMedGoogle Scholar
- Goldman D, Bateman RM, Ellis CG: Effect of sepsis on skeletal muscle oxygen consumption and tissue oxygenation: interpreting capillary oxygen transport data using a mathematical model. Am J Physiol Heart Circ Physiol. 2004, 287: H2535-H2544. 10.1152/ajpheart.00889.2003.View ArticlePubMedGoogle Scholar
- Lam C, Tyml K, Martin C, Sibbald W: Microvascular perfusion is impaired in a rat model of normotensive sepsis. J Clin Invest. 1994, 94: 2077-2083.View ArticlePubMedPubMed CentralGoogle Scholar
- Tureen J: Cerebral blood flow and metabolism in experimental meningitis. Pediatr Infect Dis J. 1989, 8: 917-918.View ArticlePubMedGoogle Scholar
- Paulson OB, Hansen EL, Kristensen HS, Brodersen P: Cerebral blood flow, cerebral metabolic rate of oxygen and CSF acid-base parameters in patients with acute pyogenic meningitis and with acute encephalitis. Acta Neurol Scand Suppl. 1972, 51: 407-408.PubMedGoogle Scholar
- Ashwal S, Stringer W, Tomasi L, Schneider S, Thompson J, Perkin R: Cerebral blood flow and carbon dioxide reactivity in children with bacterial meningitis. J Pediatr. 1990, 117: 523-530. 10.1016/S0022-3476(05)80683-3.View ArticlePubMedGoogle Scholar
- Lukasik VM, Gillies RJ: Animal anaesthesia for in vivo magnetic resonance. NMR Biomed. 2003, 16: 459-467. 10.1002/nbm.836.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2342/8/1/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.